XML 17 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jan. 27, 2024
Jan. 28, 2023
Operating activities    
Net income (loss) $ 53,620 $ (15,694)
Adjustments to reconcile net income (loss) to cash provided by operating activities:    
Depreciation and amortization 24,969 48,109
Loss from equity method investments 1,494 2,190
Loss on deconsolidation of previously controlled subsidiary   189
Amortization of debt issuance costs 638 634
Provision for doubtful accounts (67) 5
Reserve for inventory excess and obsolescence 11,668 3,787
Other non-cash expense, net 783 935
Non-cash lease expense 6,923 5,866
Loss on foreign currency transactions 54 38
Unrealized loss (gain) on available-for-sale equity securities, net 2,712 1,798
Deferred income taxes (1,604) (1,250)
Stock-based compensation 12,425 7,108
Loss on disposal of property and equipment 115 1,193
Amortization of debt securities discount   125
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 36,387 6,847
Unbilled receivables and retentions (41,950) (5,098)
Inventories (31,901) (43,111)
Income taxes receivable (8,081) (9,388)
Prepaid expenses and other assets (15,896) (3,114)
Accounts payable (10,003) 7,789
Other liabilities (15,321) (157)
Net cash provided by operating activities 26,965 8,801
Investing activities    
Acquisition of property and equipment (13,901) (10,116)
Equity method investments (1,875) (2,774)
Equity security investments   (5,100)
Acquisitions of intangible assets (1,500)  
Business acquisitions, net of cash acquired (24,156) (5,105)
Proceeds from deconsolidation of previously controlled subsidiary, net of cash deconsolidated   (635)
Redemptions of available-for-sale investments   25,945
Purchases of available-for-sale investments   (1,326)
Net cash (used in) provided by investing activities (41,432) 889
Financing activities    
Principal payments of term loan (95,000) (22,500)
Payment of contingent consideration (2,132)  
Holdback and retention payments for business acquisition (500)  
Proceeds from shares issued, net of issuance costs 88,437 20,104
Payment of debt issuance costs (37)  
Tax withholding payment related to net settlement of equity awards (1,370) (853)
Exercise of stock options   868
Other (19) (21)
Net cash provided by (used in) financing activities (10,621) (2,402)
Effects of currency translation on cash and cash equivalents (77) 695
Net (decrease) increase in cash, cash equivalents, and restricted cash (25,165) 7,983
Cash, cash equivalents and restricted cash at beginning of period 132,859 77,231
Cash, cash equivalents and restricted cash at end of period 107,694 85,214
Cash paid, net during the period for:    
Income taxes 15,195 1,192
Interest 5,850 5,697
Non-cash activities    
Unrealized gain on available-for-sale investments, net of deferred tax expense of $0 for the nine months ended January 27, 2024 and January 28, 2023, respectively   (26)
Issuance of common stock for business acquisition 109,820  
Change in foreign currency translation adjustments (436) 1,433
Issuances of inventory to property and equipment, ISR in-service assets   4,677
Acquisitions of property and equipment included in accounts payable $ 2,519 $ 731